Xgeva and Investigation abnormal - a phase IV clinical study of FDA data

Summary:

Investigation abnormal is found among people who take Xgeva, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Xgeva and have Investigation abnormal. It is created by eHealthMe based on reports of 32,257 people who have side effects when taking Xgeva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

32,257 people reported to have side effects when taking Xgeva.
Among them, 171 people (0.53%) have Investigation abnormal.

What is Xgeva?

Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 32,335 Xgeva users for its effectiveness, alternative drugs and more.

What is Investigation abnormal?

Investigation abnormal is found to be associated with 546 drugs and 245 conditions by eHealthMe.

Number of Xgeva and Investigation abnormal reports submitted per year:

Could Xgeva cause Investigation abnormal?

* Approximation only. Some reports may have incomplete information.

Do you take Xgeva and have Investigation abnormal?

Check whether Investigation abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Investigation abnormal and when was it recovered:

Investigation abnormal in Xgeva

Expand to all the drugs that have ingredients of denosumab:

Investigation abnormal and drugs with ingredients of denosumab

Alternative drugs to, pros and cons of Xgeva:

Xgeva (32,335 reports)

Common Xgeva side effects:

Death: 3,820 reports
Fatigue (feeling of tiredness): 3,203 reports
Diarrhea: 1,966 reports
Weakness: 1,454 reports
Pain: 1,157 reports

Browse all side effects of Xgeva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Investigation abnormal treatments and more:

Investigation abnormal (1,045 reports)

COVID vaccines that are related to Investigation abnormal:

Common drugs associated with Investigation abnormal:

All the drugs that are associated with Investigation abnormal:

Investigation abnormal (546 drugs)

Common conditions associated with Investigation abnormal:

Preventive health care: 518 reports
Rheumatoid arthritis: 376 reports

All the conditions that are associated with Investigation abnormal:

Investigation abnormal (245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on denosumab (the active ingredients of Xgeva) and Xgeva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.